Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback